Ionis Pharmaceuticals (IONS) Selling Pressure 'Unwarranted' - BMO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Biogen (BIIB) Weakness Overdone on Spinraza Death Fears - Mizuho
September 29, 2017 11:31 AM EDTMizuho Securities analyst Salim Syed defended Biogen (NASDAQ: BIIB) amid worries about Spinraza deaths after the FDA made its FAERS (FDA Adverse Events Reporting System) searchable by drug yesterday.
Today there is a link in circulation showing there have been 9 deaths with Spinraza.... More
Ionis Pharma (IONS) Says Deaths Not Surprising as SMA Patients Die Early - Bloomberg
September 29, 2017 10:14 AM EDTIonis Pharma (NASDAQ: IONS) Says Deaths Not Surprising as SMA Patients Die Early - Bloomberg
... MoreSarepta Therapeutics (SRPT), Ionis Pharma (IONS) Weakness Related Taking Reports Out of Context - Adam F
September 29, 2017 10:07 AM EDTAdam Feurstein weighs in on Ionis Pharma (NASDAQ: IONS) and Sarepta Therapeutics (NASDAQ: SRPT), saying weakness could be from taking death reports out of context.
Todays pastime seems to be searching FDAs FAERS database and tweeting side effects/deaths out of context. $IONS $SRPT
Adam Feuerstein (@adamfeuerstein) September 29, 2017... MoreIonis Pharma (IONS) Pressured, Down 3.5%
September 29, 2017 9:50 AM EDTIonis Pharma (NASDAQ: IONS) Pressured, Down 3.5%
... More